12 июн. 2024 г. · From precision medicine with biological therapies to innovative approaches like neurostimulation and gene therapy, the latest advancements offer renewed hope.

30 мая 2024 г. · DAZ is the first new drug under development for the treatment of SjD to reduce both systemic disease activity and an unacceptable symptom burden.

29 авг. 2024 г. · Phase two trials of Iscalimab showed at all three doses the drug had a positive effect on Sjögren's syndrome - a rheumatoid disease associated with chronic ...

23 июл. 2024 г. · Sjögren's patients can be categorised into three different subgroups, meaning that more personalised and better treatments could be possible.

15 июн. 2024 г. · Patients who received nipocalimab 15 mg/kg demonstrated a greater than 70 percent relative average improvement on the primary endpoint ...

Based on its expert opinion, the TRG recommends that SD patients with dry mouth increase saliva through gustatory, masticatory stimulation, and pharmaceutical ...

9 июл. 2024 г. · Another novel therapeutic approach under investigation for Sjögren syndrome is the use of low-dose IL-2 therapy to restore immune tolerance, ...

7 июн. 2024 г. · St. Clair led the phase 2 clinical trial for a new drug called dazodalibep, or DAZ. According to St. Clair, the medicine is believed to block ...

5 апр. 2023 г. · One potential new treatment for Sjogren's Syndrome is using Ianalumab. This is a monoclonal antibody that targets and blocks the activity of a ...

Corticosteroids, a class of drugs that includes prednisone, are fast-acting and may be highly successful in halting severe symptoms of Sjögren's and/or a flare. Clinical Practice Guidelines · Brochures & Resource Sheets · Clinical Trials